Literature DB >> 24529728

Prevalence, specificity and functionality of anti-ganglioside antibodies in neuropathy associated with IgM monoclonal gammopathy.

Abraham C J Stork1, Bart C Jacobs2, Anne P Tio-Gillen2, Marijke Eurelings3, Marc D Jansen4, Leonard H van den Berg4, Nicolette C Notermans4, W-Ludo van der Pol4.   

Abstract

IgM antibodies against gangliosides and their complexes were studied in sera from 54 patients with polyneuropathy and IgM monoclonal gammopathy (IgM-PNP) without anti-MAG antibodies. Anti-ganglioside antibodies were found in 19 (35%) patients. Five (9%) patients had antibodies against ganglioside complexes. IgM antibodies against gangliosides activated complement in vitro. Light chain usage was restricted to kappa or lambda in most, but not all patients. In conclusion, anti-ganglioside antibodies in IgM-PNP are common, display pathogenic properties and do not always arise from a monoclonal B cell proliferation.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ganglioside; Hematologic disease; Immunology; Monoclonal gammopathy of unknown significance; Peripheral neuropathy

Mesh:

Substances:

Year:  2014        PMID: 24529728     DOI: 10.1016/j.jneuroim.2014.01.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

1.  Waldenstrom-associated anti-MAG paraprotein polyneuropathy with neurogenic tremor.

Authors:  Carlo Canepa
Journal:  BMJ Case Rep       Date:  2019-03-31

Review 2.  Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.

Authors:  Hafsa M Chaudhry; Michelle L Mauermann; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2017-05       Impact factor: 7.616

3.  Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.

Authors:  Dawn L Hershman; Cathee Till; Jason D Wright; Danielle Awad; Scott D Ramsey; William E Barlow; Lori M Minasian; Joseph Unger
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

Review 4.  Advances in the Treatment of Paraproteinemic Neuropathy.

Authors:  Eduardo Nobile-Orazio; Mariangela Bianco; Andrea Nozza
Journal:  Curr Treat Options Neurol       Date:  2017-10-16       Impact factor: 3.598

Review 5.  Peripheral Nervous System Involvement in Lymphoproliferative Disorders.

Authors:  Mario Sabatelli; Luca Laurenti; Marco Luigetti
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-09-01       Impact factor: 2.576

6.  Neuropathy associated with immunoglobulin M monoclonal gammopathy: A combined sonographic and nerve conduction study.

Authors:  H Stephan Goedee; Nicolette C Notermans; Leo H Visser; Jan-Thies H van Asseldonk; Hessel Franssen; Alexander F J E Vrancken; Stavros Nikolakopoulos; Leonard H van den Berg; W Ludo van der Pol
Journal:  Muscle Nerve       Date:  2019-07-24       Impact factor: 3.217

Review 7.  Monoclonal Gammopathy of Undetermined Significance (MGUS)-Not So Asymptomatic after All.

Authors:  Oliver C Lomas; Tarek H Mouhieddine; Sabrin Tahri; Irene M Ghobrial
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.